Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia. - Wikidata - wikimedia - TriplyDB

Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia.

Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia.

http://www.wikidata.org/entity/Q42557161

about

Mapping of phospholipids by MALDI imaging (MALDI-MSI): realities and expectations Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study The Role of Omega-3 Polyunsaturated Fatty Acids in Stroke Neuroprotection and antioxidants The dynamics of the mitochondrial organelle as a potential therapeutic target Deciphering the role of docosahexaenoic acid in brain maturation and pathology with magnetic resonance imaging Detection and treatment of omega-3 fatty acid deficiency in psychiatric practice: Rationale and implementation Propofol's effect on the sciatic nerve: Harmful or protective?Unsaturated fatty acids supplementation reduces blood lead level in rats Fish oil improves motor function, limits blood-brain barrier disruption, and reduces Mmp9 gene expression in a rat model of juvenile traumatic brain injury N-3 fatty acid rich triglyceride emulsions are neuroprotective after cerebral hypoxic-ischemic injury in neonatal mice Neuroprotectin D1 attenuates laser-induced choroidal neovascularization in mouse.A rat model of mild cognitive impairment associated with vascular factor.Lipid-mediated cell signaling protects against injury and neurodegeneration.DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders.Docosahexaenoic acid regulates vascular endothelial cell function and prevents cardiovascular disease.Transgenic overproduction of omega-3 polyunsaturated fatty acids provides neuroprotection and enhances endogenous neurogenesis after stroke.Low docosahexaenoic acid status is associated with reduced indices in cortical integrity in the anterior cingulate of healthy male children: a 1H MRS Study.Omega-3 polyunsaturated fatty acids enhance cerebral angiogenesis and provide long-term protection after stroke.Treatment with docosahexaenoic acid after hypoxia-ischemia improves forepaw placing in a rat model of perinatal hypoxia-ischemia Docosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and ischemia Docosahexaenoic acid signaling modulates cell survival in experimental ischemic stroke penumbra and initiates long-term repair in young and aged rats.Omega-3 polyunsaturated fatty acid supplementation confers long-term neuroprotection against neonatal hypoxic-ischemic brain injury through anti-inflammatory actions.Docosahexaenoic Acid therapy of experimental ischemic stroke.Hippocampal neuro-networks and dendritic spine perturbations in epileptogenesis are attenuated by neuroprotectin d1.Acute treatment with docosahexaenoic acid complexed to albumin reduces injury after a permanent focal cerebral ischemia in rats.Docosahexaenoic acid improves behavior and attenuates blood-brain barrier injury induced by focal cerebral ischemia in rats.12/15-Lipoxygenase metabolites of arachidonic acid activate PPARγ: a possible neuroprotective effect in ischemic brain Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: Mechanisms and implications for psychopathology Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse.Docosahexaenoic acid pretreatment confers protection and functional improvements after acute spinal cord injury in adult rats.Enriched Endogenous Omega-3 Polyunsaturated Fatty Acids Protect Cortical Neurons from Experimental Ischemic Injury.Enriched Endogenous Omega-3 Fatty Acids in Mice Ameliorate Parenchymal Cell Death After Traumatic Brain Injury.Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil Intravenous Treatment with a Long-Chain Omega-3 Lipid Emulsion Provides Neuroprotection in a Murine Model of Ischemic Stroke - A Pilot Study Dietary Omega-3 Fatty Acids Do Not Change Resistance of Rat Brain or Liver Mitochondria to Ca(2+) and/or Prooxidants.Therapeutic use of omega-3 fatty acids in severe head trauma.Protection against Oxygen-Glucose Deprivation/Reperfusion Injury in Cortical Neurons by Combining Omega-3 Polyunsaturated Acid with Lyciumbarbarum Polysaccharide Docosahexaenoic acid complexed to human albumin in experimental stroke: neuroprotective efficacy with a wide therapeutic window Following experimental stroke, the recovering brain is vulnerable to lipoxygenase-dependent semaphorin signaling

P2860

Q23917133-21665C87-9BE5-4A02-873B-591644DCB713 Q24615766-AFE98CD8-BDC9-419F-8695-EF5CE98E1DED Q26738980-0BDA479C-58EF-4509-9B49-66E9C604DE88 Q26740098-40F903FD-ACBC-4D8B-91F6-2EC71FC73289 Q26853454-21DDF2FA-E069-4A9F-A0BD-EF44E82FCE73 Q27027307-7BB3C01B-82C2-4187-87EA-B405FB1A1D14 Q28066354-F72F5E46-C1BF-44FC-887B-8ABB3FDB9F55 Q28393150-F77010D8-6A31-46BB-9F4E-A2692D8D83E9 Q28395010-7626BB4B-2CBC-426B-BF03-AD12BE6C4CA9 Q30570065-3E3E68BF-17A3-4079-8EAA-8BAF3FB23429 Q31111679-5558097B-7C8A-4F03-8169-5EE27801B9A9 Q33539210-4F03C036-38BE-4123-A98E-3263D1B64DBB Q33643641-B7550A87-EDD6-478B-AA59-07C9EE6AE119 Q33727964-FBD36A8F-A3FD-43F5-8ED2-DBE1A375D59C Q33727970-72D06497-9FFF-4E57-B4CF-619818E75985 Q33805414-A8058D2F-6BA7-473A-A27B-9BD273608086 Q33852970-43752548-A83B-4763-A545-65B19D4AD7C7 Q33914345-2AD814E2-E734-4125-B865-92E869586B0E Q34002094-D4C8045E-4C4B-4969-B03B-570F6EE05B36 Q34163864-D48AD9D6-AEC5-499B-B155-D21C87FBBAB9 Q34363951-55BAFF23-2B4A-44E3-885A-92548B108CD2 Q34464384-BB80E963-E09F-48F9-8B35-C598C3F8D82F Q34491751-125EFA58-D358-4AA7-ADDE-43388501E3FD Q34567799-FB3B5523-ACD2-4799-AACD-0BFC61D10E44 Q35008940-373E4E07-F73C-4595-8689-EA47368AD069 Q35032398-F976B942-FCCE-4D3D-8865-4385301D40C9 Q35033401-F1A10352-65CB-4FC4-8A94-7529923C4CC3 Q35120876-C458F274-5987-4832-9663-7367BD935E47 Q35205824-CC77E957-BBFC-4E37-BD99-75C99680F66E Q35744338-A9AAEB93-3C49-40AD-881F-E67D73B0FD1D Q35754938-036A2A0E-0F53-4E9A-A930-B859EFD25FC0 Q35854060-127A19D5-FFC7-493D-A83C-63F6091F27E9 Q36014240-1FAA1921-61ED-4EC5-91C1-B5D42EB1C632 Q36049510-8E6637A6-1C21-4061-87FE-B458914BFE59 Q36208295-E21CD443-056B-4883-A939-B5ACC05D1719 Q36210621-ED5B20F9-3ED1-4BFF-A992-6726CB2DF4F3 Q36456937-C177BD7E-397C-4854-A144-C0FDE2EDB58F Q36507510-FC451BC1-11D5-47E3-9379-A8E520261D94 Q36517694-2D84DB6F-F919-4203-8AF6-1E351396A143 Q36534341-CDE937A2-144A-441D-97C9-A2B0F8D9C45E

P2860

Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia.

http://www.wikidata.org/entity/Q42557161

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Robust docosahexaenoic acid-me ...... ient, focal cerebral ischemia.

@en

Robust docosahexaenoic acid-me ...... ient, focal cerebral ischemia.

@nl

type

label

Robust docosahexaenoic acid-me ...... ient, focal cerebral ischemia.

@en

Robust docosahexaenoic acid-me ...... ient, focal cerebral ischemia.

@nl

prefLabel

Robust docosahexaenoic acid-me ...... ient, focal cerebral ischemia.

@en

Robust docosahexaenoic acid-me ...... ient, focal cerebral ischemia.

@nl

P1433

Q42557161-66636A71-6D03-4BAD-8E79-66AF16835F17

P1476

Q42557161-27DA9365-CA6F-4943-8CD3-BEE4E3D83562

P2093

Q42557161-CF7FA669-D0F1-4C70-BC02-9EA9C852222D

Q42557161-E70B3870-F6BA-4F38-BBF2-388D84136D16

Q42557161-EC05E60B-1D92-4BA3-92B6-1B064EE04410

Q42557161-FDB3D48B-1A70-42A4-8D42-EA98900F3202

P2860

Q42557161-0656880C-D228-4B50-9BFA-773858C4AB77

Q42557161-0A40800F-C9C1-4EC9-BF2D-D52229D4900A

Q42557161-2C36D3B9-2902-43DE-9E10-FD7A692647E5

Q42557161-3079AA3F-31BC-44EF-AC99-F996519AAE80

Q42557161-4FFAD560-7ADD-40F8-BF35-A82D4E71E6A6

Q42557161-503880DF-22CA-4705-93AC-9A49840CEB70

Q42557161-561C1FA3-AF75-4882-8F13-B9F0A63DF3B6

Q42557161-5A1D7E84-680F-4D7F-BD45-5673BCB094C8

Q42557161-5E9382A8-17A5-4AEB-96D8-A33B5CCA610C

Q42557161-67995CFF-13AC-4F4F-8FED-F7D734EF1535

P304

Q42557161-793A7C65-801A-4852-ABD3-5D5B86185721

P31

Q42557161-D5F4F723-7591-4E01-8E10-A0F19DF0B375

P356

Q42557161-EBD42AD2-D08A-4619-93AC-2A371362563E

P407

Q42557161-496F924C-87D7-4B62-AADC-44681C9ABF01

P433

Q42557161-8E8EA515-5E87-45A8-AA88-D6C1B06A4AB2

P478

Q42557161-D811E91B-084D-4213-88E0-B10EACD91DE2

P577

Q42557161-2ED66393-19B7-4BF1-8953-32165B78A5AB

P698

Q42557161-17962FAF-7209-40B7-A9F5-AFFEF2FF5177

P921

Q42557161-36FF3DC0-0492-4848-8B70-80A52FFEB36A

P932

Q42557161-50E3990B-F59B-4585-828B-092A7B183189

P356

STROKEAHA.109.555979

P1433

P1476

Robust docosahexaenoic acid-me ...... ient, focal cerebral ischemia.

@en

P2093

Kristal D Atkins

http://www.w3.org/2001/XMLSchema#string

Larissa Khoutorova

http://www.w3.org/2001/XMLSchema#string

Ludmila Belayev

http://www.w3.org/2001/XMLSchema#string

Nicolas G Bazan

http://www.w3.org/2001/XMLSchema#string

P2860

Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress

Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression

Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection

Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes.

Membrane docosahexaenoate is supplied to the developing brain and retina by the liver.

Molecular profile of reactive astrocytes--implications for their role in neurologic disease.

Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor.

Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors.

Docosanoids are multifunctional regulators of neural cell integrity and fate: significance in aging and disease.

Omega-3 fatty acid docosahexaenoic acid is the precursor of neuroprotectin D1 in the nervous system.

P304

3121-3126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/STROKEAHA.109.555979

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19542051

http://www.w3.org/2001/XMLSchema#string

P921

cerebral infarction

P932

2745047

http://www.w3.org/2001/XMLSchema#string